Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 1999 Sep 11;319(7211):655-6.
doi: 10.1136/bmj.319.7211.655.

Zanamivir for influenza: a public health perspective. Its use will require careful management by GPs

J S Nguyen-Van-Tam
Editorial

Zanamivir for influenza: a public health perspective. Its use will require careful management by GPs

J S Nguyen-Van-Tam. BMJ. .
No abstract available

PubMed Disclaimer

References

    1. Nguyen-Van-Tam JS. Epidemiology of influenza. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. London: Blackwell Science; 1998. pp. 181–206.
    1. Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. London: Blackwell Science; 1998. pp. 358–372.
    1. Irish C, Alli M, Gilham C, Joseph C, Watson J. Influenza vaccine uptake and distribution in England and Wales, July 1989-June 1997. Health Trends. 1998;30:51–55.
    1. Von Itzstein M, Wu W-Y, Kok GB, Pegg M, Dyason JC, Jin B, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 1993;363:418–423. - PubMed
    1. Woods JM, Bethell RC, Coates JAV, Healey N, Hiscox SA, Pearson BA, et al. 4-guanidino-2, 4-dideoxy-2, 3 dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob Agents Chemother. 1993;37:1473–1479. - PMC - PubMed

Publication types